Christian Henry

Christian Henry, CEO of Pacific Biosciences, discusses the pivotal role of DNA in genomics and the anticipated launch of the Vega system, a groundbreaking long-read sequencer priced at $169,000. He highlights how this innovation enhances access to long-read sequencing and addresses the pressing concerns over NIH funding and its potential impact on research. Henry is optimistic about the future of genomics, emphasizing the unique discoveries that long reads unlock, including those in epigenetics and disease understanding.

Exploring the impact of long reads at scale in sequencing technology. Discussing the decision between long and short reads. Plans for future instruments and insights into competing technologies.